Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand Alone Graft

Clinical application of umbilical cord blood (UCB) as a source of hematopoietic stem cells for transplantation is limited by low CD34+ cell dose, increased risk of graft failure and slow hematopoietic recovery. While the cell dose limitation is partially mitigated by using two UCB units, larger dose...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Stem Cell
Autors principals: Wagner, John E., Brunstein, Claudio G., Boitano, Anthony E., DeFor, Todd E., McKenna, David, Sumstad, Darin, Blazar, Bruce R., Tolar, Jakub, Le, Chap, Jones, Julie, Cooke, Michael P., Bleul, Conrad C.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4881386/
https://ncbi.nlm.nih.gov/pubmed/26669897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.stem.2015.10.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars